Background/aims: Small bowel bacterial overgrowth (SBBO) is defined as an abnormal increase in the number of bacteria in the small intestine, and may be occult in older adults. The aim of this study was to determine whether small bowel bacterial overgrowth (SBBO) is found in healthy older people as a concomitant of normal aging or is seen only in disabled or frail older people, excluding patients with intestinal disease and those who had undergone upper intestinal or gastric surgery.
Methodology: Forty-one relatively healthy older people, aged 74.6 +/- 1.7 (mean +/- SE) years, who engage in regular exercise, and 42 variously disabled older people, average age 78.8 +/- 1.1 years, who commute to a day-care center participated in this study. SBBO was determined by a breath hydrogen (H2) test after ingestion of 50g of glucose solution dissolved in 200mL of water. Physical activity was judged from the number of steps walked per day as measured by a pedometer. Food intake was assessed by an interview.
Results: No SBBO-positive subject was seen among the healthy, while 11 (25.6%) of the disabled older adults were positive. The number of steps/day taken by the disabled subjects was extremely low, only 22.3% of that of the healthy (P<0.001). No significant difference was seen between the groups in food intake. The mean age of the SBBO-positive patients was relatively high, 81.5 +/- 2.2 years, and 5 (45.4%) of them were underweight, with a BMI<18.5.
Conclusions: Our results and previous studies indicate that SBBO is seen only in patients with intestinal disease and disabled or frail older people.
Download full-text PDF |
Source |
---|
PLoS One
January 2025
Department of Economics, Centre for Entrepreneurship and Spatial Economics (CEnSE), Jönköping International Business School, Jönköping, Sweden.
Background: The Swedish COVID-19 strategy aimed to protect vulnerable groups through targeted measures, categorizing individuals aged 70 and above as high-risk. This study examines the impact of such group-based risk assessments on subjective health and virus-related concerns among older adults.
Methods: We analyzed survey data from the SOM Institute for 68- to 71-year-olds in 2019 (N = 684) and 2020 (N = 726).
J Gerontol A Biol Sci Med Sci
January 2025
Yale School of Public Health, Department of Biostatistics, New Haven, CT.
Background: In longitudinal studies of older persons, complete ascertainment of mortality is needed to minimize potential biases. To ascertain mortality in the National Health and Aging Trends Study (NHATS), investigators are advised to use its Sensitive files, which include month and year of death on most decedents who had not dropped out of the study. Because losses to follow-up are not insubstantial, ascertainment of mortality is likely incomplete.
View Article and Find Full Text PDFCancer Med
January 2025
Population Health Science & Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Purpose: Despite rigorous evidence of improved quality of life and longer survival, disparities in the utilization of palliative and hospice care persist for racial and ethnic minority patients with cancer. This study evaluated the impact of psychosocial factors on utilization of these services.
Methods: Patients with advanced lung cancer were recruited at a large academic urban hospital.
Prev Med Rep
November 2024
National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan.
Objectives: The World Health Organization's Integrated Care for Older People (ICOPE) framework launched in 2019 is used to assess the intrinsic capacity of older individuals. Older women may face greater socioeconomic disadvantages, which can impact their physical and mental well-being. Therefore, we examined sex differences in intrinsic capacity and the influence of socioeconomic status.
View Article and Find Full Text PDFFront Public Health
January 2025
Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Introduction: In relatively wealthy countries, substantial between-country variability in COVID-19 vaccination coverage occurred. We aimed to identify influential national-level determinants of COVID-19 vaccine uptake at different COVID-19 pandemic stages in such countries.
Methods: We considered over 50 macro-level demographic, healthcare resource, disease burden, political, socio-economic, labor, cultural, life-style indicators as explanatory factors and coverage with at least one dose by June 2021, completed initial vaccination protocols by December 2021, and booster doses by June 2022 as outcomes.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!